Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
ESMO Open
|
January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
E Agostinetto, G Pfeiler, D Hlauschek, et al.
ESMO Open
|
July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer
R Jeselsohn, J Fu, Y Ren, et al.
Molecular Psychiatry
|
March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease
M A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Molecular Psychiatry
|
May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer disease
M A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2020
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
M J M Magbanua, L B Swigart, H-T Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2021
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
A Gennari, F André, C H Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy
L Du, C Yau, L Brown-Swigart, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
May 24, 2024
Genetic associations with psychosis and affective disturbance in Alzheimer's disease
Inga Margret Antonsdottir, Byron Creese, Lambertus Klei, et al.
Annals of Surgical Oncology
|
August 21, 2025
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
M Kaur, K Dimitroff, J C Boughey, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
ESMO Open
|
January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
E Agostinetto, G Pfeiler, D Hlauschek, et al.
ESMO Open
|
July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer
R Jeselsohn, J Fu, Y Ren, et al.
Molecular Psychiatry
|
March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease
M A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Molecular Psychiatry
|
May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer disease
M A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2020
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
M J M Magbanua, L B Swigart, H-T Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2021
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
A Gennari, F André, C H Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy
L Du, C Yau, L Brown-Swigart, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
May 24, 2024
Genetic associations with psychosis and affective disturbance in Alzheimer's disease
Inga Margret Antonsdottir, Byron Creese, Lambertus Klei, et al.
Annals of Surgical Oncology
|
August 21, 2025
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
M Kaur, K Dimitroff, J C Boughey, et al.
Page
of 6